Quarterly report pursuant to Section 13 or 15(d)

Schedule of Share-based Compensation, Stock Options, Activity (Details)

v3.22.1
Schedule of Share-based Compensation, Stock Options, Activity (Details)
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Equity [Abstract]  
Shares, beginning balance | shares 80,000
Weighted average exercise price, beginning balance | $ / shares $ 7.01
Remaining contractual life in years, beginning balance 1 year 8 months 12 days
Aggregate intrinsic value, beginning balance | $
Shares, granted | shares
Weighted average exercise price, granted | $ / shares
Aggregate intrinsic value, granted | $
Shares, ending balance | shares 80,000
Weighted average exercise price, ending balance | $ / shares $ 7.01
Remaining contractual life in years, ending balance 1 year 4 months 24 days
Aggregate intrinsic value, ending balance | $
Shares, exercisable, ending balance | shares 80,000
Weighted average exercise price, exercisable, ending balance | $ / shares $ 7.01
Remaining contractual life in years, ending balance 1 year 4 months 24 days
Aggregate intrinsic value, exercisable, ending balance | $